Skip to main content

Research Repository

Advanced Search

Integrins as a drug target in liver fibrosis

Rahman, Syedia R.; Roper, James A.; Grove, Jane I.; Aithal, Guruprasad P.; Pun, K. Tao; Bennett, Andrew J.

Integrins as a drug target in liver fibrosis Thumbnail


Authors

Syedia R. Rahman

James A. Roper

Profile image of JANE GROVE

JANE GROVE jane.grove@nottingham.ac.uk
Associate Professor

K. Tao Pun



Abstract

As the worldwide prevalence of chronic liver diseases is high and continuing to increase, there is an urgent need for treatment to prevent cirrhosis-related morbidity and mortality. Integrins are heterodimeric cell-surface proteins that are promising targets for therapeutic intervention. αv integrins are central in the development of fibrosis as they activate latent TGFβ, a known profibrogenic cytokine. The αv subunit can form heterodimers with β1, β3, β5, β6 or β8 subunits and one or more of these integrins are central to the development of liver fibrosis, however, their relative importance is not understood. This review summarises the current knowledge of αv integrins and their respective β subunits in different organs, with a focus on liver fibrosis and the emerging preclinical and clinical data with regards to αv integrin inhibitors.

Citation

Rahman, S. R., Roper, J. A., Grove, J. I., Aithal, G. P., Pun, K. T., & Bennett, A. J. (2022). Integrins as a drug target in liver fibrosis. Liver International, 42(3), 507-521. https://doi.org/10.1111/liv.15157

Journal Article Type Review
Acceptance Date Dec 30, 2021
Online Publication Date Jan 20, 2022
Publication Date 2022-03
Deposit Date Jan 26, 2022
Publicly Available Date Jan 21, 2023
Journal Liver International
Print ISSN 1478-3223
Electronic ISSN 1478-3231
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 42
Issue 3
Pages 507-521
DOI https://doi.org/10.1111/liv.15157
Keywords Hepatology
Public URL https://nottingham-repository.worktribe.com/output/7340214
Publisher URL https://onlinelibrary.wiley.com/doi/10.1111/liv.15157
Additional Information This is the peer reviewed version of the following article: Rahman, S.R., Roper, J.A., Grove, J.I., Aithal, G.P., Pun, K.T. and Bennett, A.J. (2022), Integrins as a drug target in liver fibrosis. Liver International. Accepted Author Manuscript, which has been published in final form at https://doi.org/10.1111/liv.15157. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.

Files





You might also like



Downloadable Citations